Latest Breaking News On - Nct03212404 - Page 1 : comparemela.com

Long-term data demonstrated that treatment with cosibelimab improved complete response rates over time in patients with locally advanced or metastatic cutaneous squamous cell carcinoma in a phase 1 trial.

Checkpoint therapeutics incCheckpoint therapeuticsPrescription drug user fee actPatients with locally advanced or metastatic cutaneous squamous cell carcinomaJames oliviero